Nanoview Biosciences

Nanoview Biosciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 26
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $750K
Latest Deal Amount
  • Investors
  • 6

Nanoview Biosciences General Information

Description

Developer of a medical technology intended to obtain information from blood-based diagnostics. The company's technology detects nanoparticles from complex samples like whole blood, serum, plasma and urine, enabling doctors to help accurately detect and fully characterize extracellular vesicles.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • 1380 Soldiers Field Road
  • Suite 1000
  • Boston, MA 02215
  • United States
+1 (781) 000-0000

Nanoview Biosciences Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanoview Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 27-Sep-2018 $750K 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 20-Sep-2018 0000 000.00 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 06-Feb-2017 00.000 00.000 00.00 Completed Generating Revenue
2. Grant 01-Jan-2017 $452K Completed Generating Revenue
1. Grant 01-Jan-2016 Completed Generating Revenue

Nanoview Biosciences Cap Table

To view Nanoview Biosciences‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.00

Nanoview Biosciences Executive Team (4)

Name Title Board Seat Contact Info
Gerald Williamson Chief Executive Officer & Board Member
David Freedman Ph.D Co-Founder, Chief Operating Officer & President
Michael Creighton Vice President of Finance
George Daaboul Ph.D Chief Scientific Officer & Board Member

Nanoview Biosciences Board Members (6)

To view Nanoview Biosciences‘s full board member team, request access »
Name Representing Role Since
George Daaboul Ph.D Self Chief Scientific Officer & Board Member 000 0000
Gerald Williamson Nanoview Biosciences Chief Executive Officer & Board Member 000 0000
Ian Ratcliffe Sands Capital Ventures Board Member 000 0000
Michael Rubin MD Northpond Ventures Board Member 000 0000
Parker Cassidy Self Board Member 000 0000

Nanoview Biosciences Investors (6)

To view Nanoview Biosciences‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Northpond Ventures Venture Capital Minority 000 0000 000000 0
PBM Capital Group PE/Buyout Minority 000 0000 000000 0
Esco Ventures Venture Capital Minority 000 0000 000000 0
Sands Capital Ventures Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Ready to get started?

Request a free trial